Riskpilot← Back to searchSign inGet full accessGARDERMOEN HJERTESENTER AS
ASActiveOrg 918364749Skogvegen 2, 2053 JessheimMedical specialists activities · NACE 8622Est. 20173 employees
Revenue 2024
NOK 8M
+7% vs 2023
EBITDA margin
34.8%
+12% vs 2023
Equity ratio
12.5%
Financial strength
Net profit 2024
NOK 2,1M
+14% vs 2023
| Revenue | NOK 8M | +7% |
| EBITDA | NOK 2,8M | +12% |
| Net profit | NOK 2,1M | +14% |
| Total assets | NOK 2,2M | -26% |
| Equity | NOK 269K | +36% |
| Employees | 3 | — |
Legal name
GARDERMOEN HJERTESENTER AS
Org number
918364749
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
13. januar 2017
Share capital
NOK 40 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Lege- spesialist i indremedisin og hjertesykdommer, yte konsulentvirksomhet innen medisin og annet helsearbeid og tjenester som hører naturlig inn under dette. Kjøp og salg av aksjer og fond. Kjøp, salg og utleie av eiendom. Deltagelse i andre selskaper.
Address
Skogvegen 2, 2053 Jessheim
Phone
+4763996400
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 801 | 2 103 | 6 572 | 7 466 | 8 007 |
| Staff expenses | −1 239 | −1 207 | −3 892 | −3 964 | −4 099 |
| EBITDA | 515 | −67 | 1 768 | 2 486 | 2 786 |
| Depreciation & amort. | −147 | −157 | −64 | −75 | −83 |
| EBIT | 368 | −224 | 1 703 | 2 411 | 2 703 |
| Net financials | 8 | −0 | −79 | −36 | 1 |
| Profit before tax | 376 | −225 | 1 624 | 2 375 | 2 704 |
| Tax | 83 | −49 | 383 | 524 | 592 |
| Net profit | 293 | −176 | 1 241 | 1 851 | 2 112 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 651 | 462 | 3 976 | 2 916 | 2 152 |
| Equity | 333 | 157 | 1 398 | 199 | 269 |
| Long-term debt | 0 | 0 | 1 572 | 0 | 0 |
| Short-term debt | 318 | 305 | 1 006 | 2 717 | 1 882 |
| Total debt | 318 | 305 | 2 578 | 2 717 | 1 882 |
EBITDA margin
34.8%
This company
15.8%
Market median
+120% vs market
20202024
Equity ratio
12.5%
This company
38.2%
Market median
-67% vs market
20202024
Return on equity
784.0%
This company
18.4%
Market median
+4161% vs market
20202024
Net profit margin
26.4%
This company
8.1%
Market median
+226% vs market
20202024
Asset turnover
3.72×
This company
1.12×
Market median
+232% vs market
20202024
Debt / equity
6.99×
This company
0.62×
Market median
-1027% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Former (2) | ||
| Chairman | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ktmk Holding As
GARDERMOEN HJERTESENTER AS Board members of GARDERMOEN HJERTESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Magnus Heldal | Chairman | 0 companies |
| Thomas Morgan Knutsen | Chairman | 0 companies |
| Sigrid Heldal | Board of Directors | 0 companies |
| Anne Grethe Hokstad | Board of Directors | 0 companies |